Single Pass, Inc.

About Single Pass, Inc.

The startup has developed a disposable bipolar electrocautery device that cauterizes deep tissue through a guide needle, effectively sealing the biopsy channel to prevent bleeding. This technology enables physicians to obtain larger tissue samples with fewer needle passes, reducing overall procedure costs by minimizing the need for medications and hemostatic agents.

The startup has developed a disposable bipolar electrocautery device that cauterizes deep tissue through a guide needle, effectively sealing the biopsy channel to prevent bleeding. This technology enables physicians to obtain larger tissue samples with fewer needle passes, reducing overall procedure costs by minimizing the need for medications and hemostatic agents.

What does Single Pass, Inc. do?

The startup has developed a disposable bipolar electrocautery device that cauterizes deep tissue through a guide needle, effectively sealing the biopsy channel to prevent bleeding. This technology enables physicians to obtain larger tissue samples with fewer needle passes, reducing overall procedure costs by minimizing the need for medications and hemostatic agents.

Where is Single Pass, Inc. located?

Single Pass, Inc. is based in Lake Forest, United States.

How much funding has Single Pass, Inc. raised?

Single Pass, Inc. has raised $4.0M.

Who founded Single Pass, Inc.?

Single Pass, Inc. was founded by John Zehren.

  • John Zehren - Founder
Location
Lake Forest, United States
Funding
$4.0M
Employees
8 employees
Investors
K2X
SP

Single Pass, Inc.

The startup has developed a disposable bipolar electrocautery device that cauterizes deep tissue through a guide needle, effectively sealing the biopsy channel to prevent bleeding. This technology enables physicians to obtain larger tissue samples with fewer needle passes, reducing overall procedure costs by minimizing the need for medications and hemostatic agents.

Lake Forest, United States8300+ followers
Updated 2 months ago

Funding

$4.0M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Features

  • The startup has developed a disposable bipolar electrocautery device that cauterizes deep tissue through a guide needle, effectively sealing the biopsy channel to prevent bleeding. This technology enables physicians to obtain larger tissue samples with fewer needle passes, reducing overall procedure costs by minimizing the need for medications and hemostatic agents.
This profile is AI-generated and may contain inaccuracies.